State Street’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.5M | Buy |
1,629,246
+50,212
| +3% | +$1.59M | ﹤0.01% | 1662 |
|
|
2025
Q1 | $52.4M | Sell |
1,579,034
-1,781
| -0.1% | -$59.1K | ﹤0.01% | 1602 |
|
|
2024
Q4 | $54.4M | Buy |
1,580,815
+340,217
| +27% | +$11.7M | ﹤0.01% | 1676 |
|
|
2024
Q3 | $49.6M | Sell |
1,240,598
-32,900
| -3% | -$1.32M | ﹤0.01% | 1711 |
|
|
2024
Q2 | $38.4M | Sell |
1,273,498
-22,046
| -2% | -$665K | ﹤0.01% | 1795 |
|
|
2024
Q1 | $43.5M | Sell |
1,295,544
-64,903
| -5% | -$2.18M | ﹤0.01% | 1789 |
|
|
2023
Q4 | $43.9M | Buy |
1,360,447
+132,986
| +11% | +$4.3M | ﹤0.01% | 1776 |
|
|
2023
Q3 | $40.2M | Buy |
1,227,461
+86,527
| +8% | +$2.84M | ﹤0.01% | 1760 |
|
|
2023
Q2 | $40.1M | Buy |
1,140,934
+97,337
| +9% | +$3.43M | ﹤0.01% | 1801 |
|
|
2023
Q1 | $34.1M | Buy |
1,043,597
+70,814
| +7% | +$2.31M | ﹤0.01% | 1883 |
|
|
2022
Q4 | $53.6M | Sell |
972,783
-104,043
| -10% | -$5.73M | ﹤0.01% | 1586 |
|
|
2022
Q3 | $47.7M | Buy |
1,076,826
+132,491
| +14% | +$5.87M | ﹤0.01% | 1623 |
|
|
2022
Q2 | $46.1M | Buy |
944,335
+116,154
| +14% | +$5.66M | ﹤0.01% | 1701 |
|
|
2022
Q1 | $40.3M | Buy |
828,181
+52,498
| +7% | +$2.55M | ﹤0.01% | 1898 |
|
|
2021
Q4 | $33.1M | Buy |
775,683
+378,825
| +95% | +$16.2M | ﹤0.01% | 2106 |
|
|
2021
Q3 | $15.2M | Buy |
396,858
+94,068
| +31% | +$3.61M | ﹤0.01% | 2642 |
|
|
2021
Q2 | $8.55M | Buy |
302,790
+215,312
| +246% | +$6.08M | ﹤0.01% | 2994 |
|
|
2021
Q1 | $2.89M | Buy |
87,478
+4,700
| +6% | +$155K | ﹤0.01% | 3284 |
|
|
2020
Q4 | $2.99M | Buy |
+82,778
| New | +$2.99M | ﹤0.01% | 3194 |
|